VHT – Morgans rates the stock as Add
Volpara Health Technologies has signed a five-year SaaS contract with BreastScreen Queensland for the quality assurance platform, VolparaEnterprise. Morgans makes no changes to forecasts, and the Add rating and target price of $1.71 are unchanged.
Read More